deltatrials
Completed NA NCT01196377

Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study

Personalized Medicine, Biomarker-based Study of Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Acute Asthma
Interventions Albuterol
Updated 9 times since 2017 Last updated: Sep 4, 2017 Started: Sep 30, 2010 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

A NA clinical study on Acute Asthma, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Dec 2021 — Dec 2022 [monthly]

    Completed NA

▶ Show 4 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  2. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  3. Oct 2017 — Jun 2018 [monthly]

    Completed NA

  4. Jan 2017 — Oct 2017 [monthly]

    Completed NA

    First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Vanderbilt University Medical Center
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.